Characteristics of incident CKD patients, stratified by cumulative use of NSAIDs during the follow-up, and results from ordinary and cumulative logistic regressions.

<p>SD = standard deviation; 95% CI = confidence interval; adj. OR = adjusted OR; mean duration of follow-up (years): mean follow-up between date of incident CKD diagnosis (i.e. index date) and end of the follow-up.</p><p>*The analysis was adjusted by sex and age.</p><p>¹ Co-morbidities and concomitant drugs have been evaluated any time prior to the index date and they are not mutually exclusive.</p>†<p>Combination therapy consisting of vitamin A and D (ATC: A11CB) or vitamin D/vitamin D analogues (ATC: A11CC).